Alector Company Insiders

ALEC Stock  USD 1.59  0.08  4.79%   
Alector employs about 175 people. The company is managed by 18 executives with a total tenure of roughly 32 years, averaging almost 1.0 years of service per executive, having 9.72 employees per reported executive. Evaluation of Alector's management performance can provide insight into the firm performance.
Arnon Rosenthal  CEO
President CEO, Co-Founder, Director
Tillman Gerngross  Chairman
Chairman of the Board, Co-Founder
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alector. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For information on how to trade Alector Stock refer to our How to Trade Alector Stock guide.

Alector Management Team Effectiveness

The company has return on total asset (ROA) of (0.1722) % which means that it has lost $0.1722 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9026) %, meaning that it created substantial loss on money invested by shareholders. Alector's management efficiency ratios could be used to measure how well Alector manages its routine affairs as well as how well it operates its assets and liabilities.

Alector Workforce Comparison

Alector is rated second in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 795. Alector totals roughly 175 in number of employees claiming about 22% of equities under Health Care industry.
The company has Profit Margin (PM) of (1.4) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (12.17) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $12.17.

Alector Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Alector insiders, such as employees or executives, is commonly permitted as long as it does not rely on Alector's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Alector insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Alector Notable Stakeholders

An Alector stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Alector often face trade-offs trying to please all of them. Alector's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Alector's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Arnon RosenthalPresident CEO, Co-Founder, DirectorProfile
Tillman GerngrossChairman of the Board, Co-FounderProfile
Sara KenkareMitraPresident DevelopmentProfile
Calvin YuVice President - FinanceProfile
Saraswati KenkareMitraPresident DevelopmentProfile
Virginia MBAChief StrategyProfile
Norah ConwayProgram PortfolioProfile
Gary MDChief OfficerProfile
Katie HoganSenior RelationsProfile
Marc MDChief OfficerProfile
Kristina MPHPharmacovigilance, RegulatoryProfile
Giacomo MDChief OfficerProfile
Michelle CorralVP RelationsProfile
MS MBAInterim OfficerProfile
Peter HeutinkChief OfficerProfile
Danielle JDGeneral CounselProfile
Clare MBAChief OfficerProfile
Erica JeffersonVP AffairsProfile

About Alector Management Performance

The success or failure of an entity such as Alector often depends on how effective the management is. Alector management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Alector management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Alector management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. The company was founded in 2013 and is headquartered in South San Francisco, California. Alector operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 269 people.
Please note, the presentation of Alector's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Alector's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Alector's management manipulating its earnings.

Alector Workforce Analysis

Traditionally, organizations such as Alector use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Alector within its industry.

Alector Manpower Efficiency

Return on Alector Manpower

Revenue Per Employee574.6K
Revenue Per Executive5.6M
Net Loss Per Employee680.3K
Net Loss Per Executive6.6M
Working Capital Per Employee1.7M
Working Capital Per Executive16.7M

Complementary Tools for Alector Stock analysis

When running Alector's price analysis, check to measure Alector's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alector is operating at the current time. Most of Alector's value examination focuses on studying past and present price action to predict the probability of Alector's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alector's price. Additionally, you may evaluate how the addition of Alector to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Fundamental Analysis
View fundamental data based on most recent published financial statements